Concerning the extracellular matrix (ECM) members in MS, such as collagen, we propose that these miRNAs control the inflammatory response and treatment induces repair since the crosstalk between the ECM and immune responses (IL-4 and Il-13) is known to modulate lesions for recovery or worsening (46). The gene discussed is IL13; the disease is myeloid sarcoma.